Recientemente se han producido importantes avances en el conocimiento de la biopatología,
la epidemiología y el pronóstico de la hipertensión pulmonar que han cambiado la …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

A pulmonary hypertension (PH) registry (Spanish Registry of Pulmonary Arterial Hypertension)
was undertaken to analyse prevalence, incidence and survival of pulmonary arterial …

Registries of patients with pulmonary arterial hypertension (PAH) have been instrumental in
characterizing the presentation and natural history of the disease and provide a basis for …

Guidelines summarize and evaluate available evidence, with the aim of assisting health
professionals in proposing the best management strategies for an individual patient with a given …

Background Pulmonary arterial hypertension is characterized by pulmonary vascular
remodeling, cellular proliferation, and poor long-term outcomes. Dysfunctional bone …

Aims We aimed to determine whether treatment with sildenafil improves outcomes of patients
with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD…

Aims To validate the modified World Health Organization ( mWHO ) risk classification in
advanced and emerging countries, and to identify additional risk factors for cardiac events during …

La hipertensión pulmonar primaria es una enfermedad de carácter progresivo, más frecuente
en mujeres jóvenes y de mediana edad. Su etiología se desconoce, aunque existe una …

Background In participants with pulmonary arterial hypertension, 24 weeks of sotatercept
resulted in a significantly greater reduction from baseline in pulmonary vascular resistance …